Alnylam Pharmaceuticals
ALNY
#636
Rank
S$41.05 B
Marketcap
$317.19
Share price
-0.59%
Change (1 day)
62.05%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cost to borrow shares

Latest borrow fee for Alnylam Pharmaceuticals (ALNY) shares on Interactive Brokers: 0.4081% (annualized)

Shares available to borrow: 1000000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Alnylam Pharmaceuticals (ALNY) - cost to borrow in the last 7 days chart

Alnylam Pharmaceuticals (ALNY) - number of shares available to borrow in the last 7 days

Alnylam Pharmaceuticals (ALNY) - cost to borrow from 2025 to 2023

Alnylam Pharmaceuticals (ALNY) - number of shares available to borrow from 2025 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
0.3871%1.1 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4081%1.5 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.25%1.5 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.5263%6.5 M๐Ÿ‡บ๐Ÿ‡ธ USA
3.2763%0.35 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.25%0.3 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
0.3457%0.4 M๐Ÿ‡ซ๐Ÿ‡ท France
0.25%10 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel